Advertisement

FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight into the needs of research scientists; boost effective product development decisions; streamline marketing budgets; learn how to gain more market share; understand the key strengths and weaknesses of competitors and identify opportunities.

(Logo: http://photos.prnewswire.com/prnh/20120725/CG46150)

Mesenchymal Stem Cells – Advances & Applications

In BioInformant's recently launched market report, analysis of grant activity, publications, and patent applications reveals that Mesenchymal Stem Cell (MSC) research activity increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Mesenchymal stem cells now represent fastest growing area of stem cell research.  While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products.

The new report identifies recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. It is your guide for how to profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research. 

To vi
'/>"/>

Advertisement
Advertisement